Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.60 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TERT | O14746 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | CD44 | P16070 | 1/20 | 0.40 |
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.37 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL916066 | 0.89 | CYP3A4 (0.60) | CYP3A4TSHRMAPK1ALDH1A1CYP1A2 | |
| SCHEMBL17404432 | 0.83 | CYP3A4 (0.60) | CYP3A4TSHRMAPK1ALDH1A1CYP1A2 | |
| SCHEMBL19370479 | 0.83 | CYP3A4 (0.39) | CYP3A4TSHRMAPK1ALDH1A1CYP1A2 | |
| SCHEMBL11818230 | 0.83 | CYP3A4 (0.52) | CYP3A4TSHRMAPK1ALDH1A1CYP1A2 | |
| SCHEMBL33943 | 0.82 | CYP3A4 (0.86) | CYP3A4TSHRMAPK1ALDH1A1CYP1A2 | |
| SCHEMBL3185677 | 0.82 | ALDH1A1 (0.34) | CYP3A4TSHRMAPK1ALDH1A1TDP1 | |
| SCHEMBL8601969 | 0.80 | CYP3A4 (0.55) | CYP3A4TSHRMAPK1ALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL8640327 | 0.78 | CYP3A4 (0.80) | CYP3A4TSHRMAPK1ALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL8640325 | 0.78 | CYP3A4 (0.80) | CYP3A4TSHRMAPK1ALDH1A1CYP1A2 | |
| SCHEMBL9523992 | 0.77 | CD44 (0.52) | CYP3A4TSHRMAPK1ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240336599-A1 | PHOTOSENSITIVE POLYAMIC ACID AND DIAZIRINE COMPOSITIONS | PROMERUS, LLC (US) | 2024-10-10 | — | — | US | claimed |
| US-20240336599-A1 | PHOTOSENSITIVE POLYAMIC ACID AND DIAZIRINE COMPOSITIONS | PROMERUS, LLC (US) | 2024-10-10 | — | — | US | disclosed |
| US-20200285151-A1 | PHOTOSENSITIVE POLYIMIDE COMPOSITIONS | PROMERUS, LLC (US) | 2020-09-10 | — | — | US | disclosed |
| US-6303822-B1 | Aromatic hydroxythiol synthesis using diazonium salts | ALLIEDSIGNAL INC. | 2001-10-16 | — | — | US | disclosed |
| EP-1140816-A1 | AROMATIC HYDROXYTHIOL SYNTHESIS USING DIAZONIUMSALTS | AlliedSignal Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000037439-A1 | AROMATIC HYDROXYTHIOL SYNTHESIS USING DIAZONIUM SALTS | ALLIEDSIGNAL INC. (US) | 2000-06-29 | — | — | WO | disclosed |
| US-6054622-A | Aromatic hydroxythiol synthesis using diazonium salts | ALLIEDSIGNAL INC (US) | 2000-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240336599-A1 | PHOTOSENSITIVE POLYAMIC ACID AND DIAZIRINE COMPOSITIONS | PUF60, FTO, PARN | CYP3A4 4874/4885TSHR 4589/4885MAPK1 3836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.